CLEVELAND, Ohio — The nation's three largest drug distributors and a drugmaker have reached a tentative deal to settle a lawsuit related to the nation's opioid crisis.
The agreement comes within hours of the first federal trial over the crisis, with opening statements scheduled for Monday in Cleveland.
The tentative settlement involves drug distributors AmerisourceBergen, Cardinal Health and McKessen and drug manufacturer Teva.
Purdue Pharma, maker of OxyContin, is trying to settle opioid lawsuits through bankruptcy court.
It's not clear what will happen with remaining litigation if the settlements are finalized.
The deal was first reported by The Wall Street Journal and was confirmed to The Associated Press by Paul Hanly, a lead lawyer for the local governments suing the drug industry.
Niall Janney of Sunshine Sachs released a statement from the Plaintiffs' Executive Committee.
"While this morning's trial will not begin as scheduled, the federal opioid MDL continues to move forward, as thousands of American communities still have claims against opioid industry defendants."
The settlement agreement is between Cuyahoga and Summit Counties and Teva Pharmaceutical, Cardinal Health, McKesson and AmerisourceBergen.